“…Because MST targets specific constituents of the gut microbiota, the diagnostic performance of each MST marker can vary substantially between populations. Validation of existing MST markers for use in new geographic locations is increasingly standard practice [24], with recently published MST validation studies conducted in Australia [67,68], Bangladesh [69,70], Costa Rica [71], India [72], Japan [73,74], Mozambique [75], New Zealand [76], Nepal [77,78], Singapore [79], Thailand [80], and the USA [81,82], and a global evaluation of markers in sewage from 13 countries on 6 continents [83•]. Potential MST markers continue to be identified, most notably humanassociated crAssphage, a bacteriophage infecting Bacteroides intestinalis recently discovered to be an abundant, globally distributed constituent of the human gut virome [84][85][86][87][88][89].…”